TNF and graft versus host disease: In the context of GVHD after allogeneic HSCT, biomarker research has progressed through a variety of techniques, such as immunocompetent cells (CD4 helper T cells, regulatory T cells), plasma (soluble IL-2R), and inflammatory cytokines (IFN-γ, TNF-α).